All Posts
Characteristics and Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease
21 May, 2020 | 09:18h | UTCCommentary: Outcomes of Patients Hospitalized for COVID-19 and Cardiac Disease – American College of Cardiology
Cardiovascular Considerations in Treating Patients with COVID-19
21 May, 2020 | 09:16h | UTCRelated: Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis – Current Problems in Cardiology AND Cardiology After COVID-19: Physicians Predict Lasting Change – TCTMD
See also: COVID-19: Updates for Cardiologists
COVID-19 in Children: Clinical Approach and Management
21 May, 2020 | 09:19h | UTCCOVID-19 in Children: Clinical Approach and Management – The Indian Journal of Pediatrics
Related Systematic Reviews: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries) AND SARS-CoV-2 (COVID-19): What do we know about children? A systematic review – Clinical Infectious Diseases
Rate of Diagnostic Errors and Related Harms for Major Vascular Events, Infections, and Cancers
21 May, 2020 | 09:14h | UTCCommentary: Misdiagnoses Common, With Permanent Disability, Death for Many – Medscape (free registration required)
Review: Artificial Intelligence and the Future of Global Health
21 May, 2020 | 09:11h | UTCArtificial intelligence and the future of global health – The Lancet (free registration required)
Systematic Review: Safety and Adverse Effects of 80 Antidepressants, Antipsychotics, Anti‐attention‐deficit/hyperactivity Medications and Mood Stabilizers in Children and Adolescents
21 May, 2020 | 09:10h | UTC
Neurologic Complications of COVID-19
21 May, 2020 | 09:15h | UTCNeurologic complications of COVID-19 – American Journal of Emergency Medicine
Related: Neurologic Features in Severe SARS-CoV-2 Infection – New England Journal of Medicine AND Neurologic Manifestations Common in Hospitalized Patients with Covid-19 (study and commentaries) AND Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19 – Neurology
ASCO Guideline: Management of Cancer Cachexia
21 May, 2020 | 09:13h | UTCManagement of Cancer Cachexia: ASCO Guideline – Journal of Clinical Oncology
Thrombolysis with Alteplase 3–4.5 hours After Acute Ischemic Stroke: Trial Reanalysis Adjusted for Baseline Imbalances
21 May, 2020 | 09:09h | UTC
[No Publication Available] Covid-19 Patients Testing Positive After Recovery Aren’t Infectious
20 May, 2020 | 10:00h | UTCCovid Patients Testing Positive After Recovery Aren’t Infectious, Study Shows – Bloomberg
Why Saliva Tests Could Offer a Better Alternative to Nasal COVID-19 Swabs
20 May, 2020 | 09:58h | UTCOriginal Article: Saliva—Friend and Foe in the COVID-19 Outbreak – Diagnostics
Editorial: Lack of Efficacy of Hydroxychloroquine in Covid-19
20 May, 2020 | 10:01h | UTCLack of efficacy of hydroxychloroquine in covid-19 – The BMJ
Original Research: Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ
Related Meta-analysis (preprint) Hydroxychloroquine in COVID-19: A systematic review and meta-analysis – medRxiv
Reducing the Risk of Diagnostic Error in the COVID-19 Era
20 May, 2020 | 09:57h | UTCReducing the Risk of Diagnostic Error in the COVID-19 Era – Journal of Hospital Medicine
Video: Personal Protective Equipment and Covid-19
20 May, 2020 | 09:55h | UTCPersonal Protective Equipment and Covid-19 – New England Journal of Medicine
Why do Some COVID-19 Patients Infect Many Others, Whereas Most Don’t Spread the Virus at All?
20 May, 2020 | 09:52h | UTC
Cohort Study: Outcomes of Critically Ill Adults with COVID-19 in New York City
20 May, 2020 | 09:56h | UTCCommentaries: Critically ill patients with COVID-19 in New York City – The Lancet AND Nearly 40% of critically ill COVID-19 patients in New York City died, study finds – UPI
Study Shows Lower Incidence of Hospitalization for Acute Myocardial Infarction After the Covid-19 Pandemic
20 May, 2020 | 09:54h | UTCRelated Study: Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy – New England Journal of Medicine
Serology for SARS-CoV-2: Apprehensions, Opportunities, and the Path Forward
20 May, 2020 | 09:53h | UTCSerology for SARS-CoV-2: Apprehensions, opportunities, and the path forward – Science Immunology
Lack of Cross-neutralization by SARS Patient Sera Towards SARS-CoV-2
20 May, 2020 | 09:49h | UTC
[Preprint] The Infection Fatality Rate of COVID-19 Inferred from Seroprevalence Data
20 May, 2020 | 09:51h | UTCThe infection fatality rate of COVID-19 inferred from seroprevalence data – medRxiv
Related Commentary on Twitter
The infection fatality rate of COVID-19 inferred from seroprevalence data – a paper by John Ioannidis with a discussion of methodological issues that should stimulate much useful discussion| medRxiv https://t.co/Y2u3LsQW0T
— Jeffrey Flier (@jflier) May 19, 2020
Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19
20 May, 2020 | 09:50h | UTCRelated Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv
Meta-Analysis: Accuracy of Chest CT for detecting COVID-19
20 May, 2020 | 09:49h | UTC
Meta-Analysis: Association of Blood Pressure Lowering with Incident Dementia or Cognitive Impairment
20 May, 2020 | 09:45h | UTCAssociation of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis – JAMA (free for a limited period)
Commentary: Controlling blood pressure may reduce dementia risk by 7% – UPI
Caring for Critically Ill Adults With Coronavirus Disease 2019 in a PICU
20 May, 2020 | 09:46h | UTCRelated: Repurposing a Pediatric ICU for Adults – New England Journal of Medicine
Meta-analysis: Utility of Broad-spectrum Antibiotics for Diagnosing Pulmonary Tuberculosis in Adults
20 May, 2020 | 09:44h | UTCCommentary: The uncertainty of tuberculosis diagnosis – The Lancet Infectious Diseases